Somewhat Positive Media Coverage Somewhat Unlikely to Affect National Health Investors (NHI) Stock Price

News articles about National Health Investors (NYSE:NHI) have trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. National Health Investors earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media stories about the real estate investment trust an impact score of 47.3852126013314 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the media stories that may have effected Accern Sentiment’s scoring:

National Health Investors (NHI) traded down $1.37 during trading hours on Monday, reaching $69.74. The company had a trading volume of 302,900 shares, compared to its average volume of 219,933. The company has a market cap of $2,900.00, a P/E ratio of 17.44, a price-to-earnings-growth ratio of 3.29 and a beta of 0.59. National Health Investors has a one year low of $68.96 and a one year high of $81.60. The company has a quick ratio of 12.72, a current ratio of 12.72 and a debt-to-equity ratio of 0.84.

National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, November 8th. The real estate investment trust reported $0.94 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.34 by ($0.40). National Health Investors had a return on equity of 12.74% and a net margin of 59.70%. research analysts anticipate that National Health Investors will post 5.26 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be given a $0.95 dividend. The ex-dividend date is Thursday, December 28th. This represents a $3.80 dividend on an annualized basis and a yield of 5.45%. National Health Investors’s payout ratio is 95.00%.

A number of analysts have recently issued reports on NHI shares. KeyCorp reiterated a “hold” rating on shares of National Health Investors in a research report on Sunday, September 17th. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $89.00 price target for the company in a research report on Thursday, September 21st. Stifel Nicolaus reiterated a “buy” rating and set a $82.00 price target on shares of National Health Investors in a research report on Wednesday, October 4th. Mizuho reiterated a “hold” rating and set a $82.00 price target on shares of National Health Investors in a research report on Wednesday, October 4th. Finally, SunTrust Banks initiated coverage on National Health Investors in a research report on Tuesday, October 10th. They set a “hold” rating and a $80.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $80.00.

WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect National Health Investors (NHI) Stock Price” was published by Transcript Daily and is owned by of Transcript Daily. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://transcriptdaily.com/2018/01/16/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-national-health-investors-nhi-stock-price.html.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply